Terminated PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT00205907

Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation

Phase 1/Phase 2 Study of the Aeris Bronchoscopic Lung Volume Reduction (BLVR) System in Patients With Advanced Emphysema

Sponsor: Aeris Therapeutics

Conditions Pulmonary Emphysema

Interventions BLVR Hydrogel

Updated 5 times since 2017 Last updated: Feb 27, 2008 Started: Jan 31, 2005 Primary completion: Aug 31, 2006 Completion: Apr 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Change in Formulation

Other terminated trials from Aeris Therapeutics

See all terminations from Aeris Therapeutics

Other Pulmonary Emphysema trials with similar outcome

Browse all Pulmonary Emphysema trials

Listed as NCT00205907, this PHASE1/PHASE2 trial focuses on Pulmonary Emphysema and remains terminated or withdrawn. Sponsored by Aeris Therapeutics, it has been updated 5 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE1_PHASE2

First recorded

Jan 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aeris Therapeutics

Data source: Aeris Therapeutics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ramat Gan, Israel